Loading...

501 posters, 2 videos, 1 audios, 8 topics, 37 sessions, 395 authors, 307 institutions

ePostersLive by SciGen Technologies S.A. All rights reserved.

23rd Annual Pain Medicine Meeting 2024

November 21-23, 2024 | Caesars Palace, Las Vegas, Nevada

23rd Annual Pain Medicine Meeting 2024 banner

5904

EFFECTS OF EPIDURAL DEXMEDETOMIDINE ON PATIENT CONTROLLED EPIDURAL ANALGESIA AFTER TOTAL KNEE REPLACEMENT ARTHROPLASTY

Part of Topic

Scientific Abstracts > Regional Anesthesia

Effects of epidural dexmedetomidine on
patient controlled epidural analgesia
after total knee arthroplasty:
A Single-Center Prospective Double-Blind Randomized Controlled Study
Jaesuk Kim, So young Kwon and Jin Deok Joo
Department of Anesthesiology and Pain Medicine, Saint Vincent’s Hospital, College of medicine, Catholic University of Korea, Suwon, Korea

INTRO
• Managing postoperative pain in total knee arthroplasty
(TKA) patients is crucial.
• Adding epidural dexmedetomidine to local anesthetics
(LA) can improve pain control and reduce side effects.
• This study investigates the effects of epidural
dexmedetomidine combined with low concentration
PCEA on pain control and side effects.
METHODS
• Participants: N = 60 ASA I-II patients undergoing TKA
• Divided into 2 Groups
- Group R (0.125% bupivacaine + fentanyl 4 mcg/ml)
- Group D (0.1% bupivacaine + fentanyl 2 mcg/ml), with
an epidural dexmedetomidine 1 mcg/kg
• Assessment : Hemodynamic parameters, pain scale,
and side effects were assessed intraoperatively and
postoperatively
RESULTS
• No significant differences were found in NRS, DOS,
DOA, rescue analgesics, and ephedrine usage.
• Urinary retention was significantly higher in Group R at
24 hours, while sedation was higher in Group D in the
recovery room
• Pruritus was higher in Group R at 18 and 30 hours

23rd Annual Pain Medicine Meeting 2024 » banner
Copyright © 2015-2026, ePostersLive® SciGen is a registered trademark of SciGen Technologies S.A. Patent pending.

This website and third-party tools we use rely on cookies for the best user experience. By selecting "I agree", you agree to cookie usage as described in our Privacy Policy.